✦ LIBER ✦

Ziprasidone versus risperidone in schizophrenia: An eight-week, double-blind trial with forty four-week continuation

✍ Scribed by I. Benattia; D. Addington; C. Pantelis; M. Dineen; S. Murray

Book ID: 119555537
Publisher: Elsevier Science
Year: 2003
Tongue: English
Weight: 126 KB
Volume: 60
Category: Article
ISSN: 0920-9964
DOI: 10.1016/s0920-9964(03)80431-0

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Ziprasidone vs risperidone in schizophre

Ziprasidone vs risperidone in schizophrenia: An 8-week, double-blind trial

✍ D. Addington; C. Pantelis; I. Benattia 📂 Article 📅 2002 🏛 Elsevier Science 🌐 English ⚖ 117 KB

Olanzapine Versus Placebo in Adolescents

Olanzapine Versus Placebo in Adolescents With Schizophrenia: A 6-Week, Randomized, Double-Blind, Placebo-Controlled Trial

✍ Kryzhanovskaya, Ludmila; Schulz, S. Charles; Mcdougle, Christopher; Frazier, Jea 📂 Article 📅 2009 🏛 Elsevier Science 🌐 English ⚖ 198 KB

P.3.a.047 Remission in schizophrenia: a

P.3.a.047 Remission in schizophrenia: a comparison of 2 dose regimens of ziprasidone versus haloperidol in a 40-week core and 3-year double-blind continuation study

✍ F. Rappard; A. Loebel; L. Warrington; C. Siu; J.A. Lieberman 📂 Article 📅 2006 🏛 Elsevier Science 🌐 English ⚖ 58 KB

P.3.127 A randomised, double-blind clini

P.3.127 A randomised, double-blind clinical trial comparing treatment with amisulpride or risperidone for six weeks in elderly patients with schizophrenia

📂 Article 📅 2005 🏛 Elsevier Science 🌐 English ⚖ 121 KB

Safety and efficacy of ocrelizumab in pa

Safety and efficacy of ocrelizumab in patients with rheumatoid arthritis and an inadequate response to methotrexate: Results of a forty-eight–week randomized, double-blind, placebo-controlled, parallel-group phase III trial

✍ W. Rigby; H.-P. Tony; K. Oelke; B. Combe; A. Laster; C. A. von Muhlen; E. Fishel 📂 Article 📅 2012 🏛 John Wiley and Sons 🌐 English ⚖ 112 KB 👁 2 views

Efficacy and safety of four doses of lum

Efficacy and safety of four doses of lumiracoxib versus diclofenac in patients with knee or hip primary osteoarthritis: A phase II, four-week, multicenter, randomized, double-blind, placebo-controlled trial

✍ Schnitzer, Thomas J. ;Beier, Jannie ;Geusens, Piet ;Hasler, Paul ;Patel, Sanjay 📂 Article 📅 2004 🏛 John Wiley and Sons 🌐 English ⚖ 128 KB 👁 3 views

## Abstract ## Objective To compare the efficacy and tolerability of the novel cyclooxygenase 2‐selective inhibitor lumiracoxib with placebo and diclofenac in osteoarthritis (OA). ## Methods Adults (n = 583) with knee or hip OA were randomized to receive for 4 weeks lumiracoxib 50, 100, or 200 m